Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells.
about
Resistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy?Clinical significance of MET in gastric cancerReceptor tyrosine kinase Met promotes cell survival via kinase-independent maintenance of integrin α3β1Autophagy and cancer therapy.Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapiesMET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.Functional analysis of a novel glioma antigen, EFTUD1.The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcomaSIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment.The novel kinase inhibitor EMD1214063 is effective against neuroblastoma.Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells.CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.Autophagy is required for crizotinib-induced apoptosis in MET-amplified gastric cancer cells.mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism.Cell death-based treatment of lung adenocarcinoma.SIRT1 in Secretory Organ Cancer
P2860
Q26739760-5A9F7EC9-4F5E-42AE-89BE-D034E9A5CE8BQ26776190-4AC255AC-59CB-4585-8AC9-B9A2BCD545BCQ30791975-C3CE7469-1DEA-46B8-B0B8-844C0D9D6822Q33584607-1CACEA81-8E96-4A08-9DDB-E3666A6CE573Q34158454-3FAA5724-C8CE-418E-AC62-DD9A8BDB551FQ34182679-4A602C0C-E5F6-4ED7-A417-FF4B186ABCE8Q35205668-26A35E80-887C-4C6B-93ED-0C6582371E9DQ35904618-C5F0C157-CA7F-4FE1-9A4C-AC4D15259934Q38517916-1F333CC1-F337-401F-80D7-E3A9AC879DB7Q38994569-328F0A56-92B1-4E29-ACC3-F525127ADE4FQ39030337-7DE4510C-8EED-4BE1-AFE1-A5613F9F2D63Q39243936-B0E37AD1-5BC8-40A8-85F1-D9BE4BBC61F6Q41612961-F3C1D669-AC26-4501-BF04-AEC2D8EF8B43Q42509388-EA2511EF-0B16-477E-B9F4-BD42CDCC4BDEQ47711273-7AB704BF-FD8B-4517-8367-D18F41D339E9Q57492359-59D5481D-5971-494D-8FDA-255E4565DD8C
P2860
Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Protective autophagy is involv ...... gastric adenocarcinoma cells.
@en
Protective autophagy is involv ...... gastric adenocarcinoma cells.
@nl
type
label
Protective autophagy is involv ...... gastric adenocarcinoma cells.
@en
Protective autophagy is involv ...... gastric adenocarcinoma cells.
@nl
prefLabel
Protective autophagy is involv ...... gastric adenocarcinoma cells.
@en
Protective autophagy is involv ...... gastric adenocarcinoma cells.
@nl
P2093
P50
P1476
Protective autophagy is involv ...... n gastric adenocarcinoma cells
@en
P2093
Andree Blaukat
Daniel M Aebersold
Friedhelm Bladt
Martin F Fey
Yitzhak Zimmer
P304
P356
10.1016/J.BBRC.2012.12.120
P407
P577
2013-01-09T00:00:00Z